Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Alimentary pharmacology & therapeutics - 45(2017), 5, Seite 631-642 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Savarino, V [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
doi: |
10.1111/apt.13914 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1993058230 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1993058230 | ||
003 | DE-627 | ||
005 | 20230512163954.0 | ||
007 | tu | ||
008 | 170512s2017 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1111/apt.13914 |2 doi | |
028 | 5 | 2 | |a PQ20170721 |
035 | |a (DE-627)OLC1993058230 | ||
035 | |a (DE-599)GBVOLC1993058230 | ||
035 | |a (PRQ)c1344-b98886d89931c1c6439a0653807d37f3d2c14287faa510c23d6ae3f8ad990a6e0 | ||
035 | |a (KEY)0157873120170000045000500631randomisedclinicaltrialmucosalprotectioncombinedwi | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DE-600 |
084 | |a 44.87 |2 bkl | ||
084 | |a 44.38 |2 bkl | ||
100 | 1 | |a Savarino, V |e verfasserin |4 aut | |
245 | 1 | 0 | |a Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
540 | |a Nutzungsrecht: © 2017 The Authors. published by John Wiley & Sons Ltd. | ||
700 | 1 | |a Pace, F |4 oth | |
700 | 1 | |a Scarpignato, C |4 oth | |
700 | 1 | |a Astegiano, Marco |4 oth | |
700 | 1 | |a Calabrese, Carlo |4 oth | |
700 | 1 | |a Cicala, Michele |4 oth | |
700 | 1 | |a Ciliberto, Enrico |4 oth | |
700 | 1 | |a Conigliaro, Rita |4 oth | |
700 | 1 | |a Costamagna, Guido |4 oth | |
700 | 1 | |a Cuomo, Rosario |4 oth | |
700 | 1 | |a Di Leo, Alfredo |4 oth | |
700 | 1 | |a Di Simone, Massimo Pierluigi |4 oth | |
700 | 1 | |a Esposito, Pasquale |4 oth | |
700 | 1 | |a Groppo, Marzia |4 oth | |
700 | 1 | |a Marchi, Santino |4 oth | |
700 | 1 | |a Neri, Matteo |4 oth | |
700 | 1 | |a Pace, Fabio |4 oth | |
700 | 1 | |a Savarino, Vincenzo |4 oth | |
700 | 1 | |a Segato, Sergio |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d Oxford : Wiley-Blackwell, 1987 |g 45(2017), 5, Seite 631-642 |w (DE-627)130433233 |w (DE-600)639012-2 |w (DE-576)028460936 |x 0269-2813 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2017 |g number:5 |g pages:631-642 |
856 | 4 | 1 | |u http://dx.doi.org/10.1111/apt.13914 |3 Volltext |
856 | 4 | 2 | |u http://onlinelibrary.wiley.com/doi/10.1111/apt.13914/abstract |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.87 |q AVZ |
936 | b | k | |a 44.38 |q AVZ |
951 | |a AR | ||
952 | |d 45 |j 2017 |e 5 |h 631-642 |